Rivia Research Pte Ltd is a Singapore registered company specializing in medical research. Working with a team of global experts in the field of translational research, we aim to cut short the long life-cycle of traditional drug development by exploring new applications of existing drugs to create a significant impact on patient healthcare.
Using existing, generic drugs allows us to take advantage of the decades of safety data and history of comprehensive understanding about all aspects of these drugs systemic effects and interactions. We leverage on this body of clinical knowledge and published literature to greatly accelerate regulatory approval for new clinical indications.
Ivan Howden MACEO
Dr Richard Buchta BSc, MBA, PhDCSO